618900-48-4 Usage
Uses
Used in Pharmaceutical Development:
7-(Bromomethyl)-3-trityl-3H-imidazo[4,5-b]pyridine is used as a research chemical for the development of pharmaceuticals. Its unique structure, featuring both a trityl group and a bromomethyl group, allows for its potential use in the synthesis of various drug candidates.
Used in Organic Synthesis:
In the field of organic synthesis, 7-(Bromomethyl)-3-trityl-3H-imidazo[4,5-b]pyridine is used as a building block or intermediate for the creation of more complex organic compounds. Its versatility in chemical reactions makes it a valuable component in the synthesis of a wide range of molecules.
Used in Chemical Research:
7-(Bromomethyl)-3-trityl-3H-imidazo[4,5-b]pyridine is also used in chemical research to study the properties and reactivity of heterocyclic compounds. Its unique structure provides researchers with opportunities to explore new reaction pathways and mechanisms, contributing to the advancement of organic chemistry.
Note: Since the provided materials do not specify particular industries or detailed applications, the uses listed above are general and based on the compound's characteristics and potential in the fields of pharmaceutical development, organic synthesis, and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 618900-48-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,8,9,0 and 0 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 618900-48:
(8*6)+(7*1)+(6*8)+(5*9)+(4*0)+(3*0)+(2*4)+(1*8)=164
164 % 10 = 4
So 618900-48-4 is a valid CAS Registry Number.
618900-48-4Relevant academic research and scientific papers
BENZIMIDAZOLE DERIVATIVES AND METHODS OF USE THEREOF
-
, (2008/12/08)
The present invention relates to compounds of formula (I); compositions comprising the compounds, and methods of using the compounds to treat or prevent pain, diabetes, a diabetic complication, impaired glucose tolerance (IGT) or impaired fasting glucose